Navigation Links
Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Release of New Order in Federal Ethicon Vaginal Mesh Litigation

New York, New York (PRWEB) August 28, 2013

Thousands of transvaginal mesh lawsuits ( alleging serious injuries due to Ethicon Inc.’s Gynecare pelvic mesh products continue to move forward in a multidistrict litigation underway in U.S. District Court, Southern District of West Virginia, Bernstein Liebhard LLP reports. According to a Pretrial Order issued by the Court on August 26, 2013, procedures have been established for the selection of vaginal mesh lawsuits for the litigation’s first bellwether trials involving Gynecare Prolift devices. The first of those trials is scheduled to begin on August 19, 2014. (In re: Ethicon, Inc., Pelvic Repair Systems Products Liability Litigation - MDL No. 2327)

“Our Firm is representing numerous women who have suffered serious vaginal mesh complications, allegedly due to the defective nature of Gynecare Prolift mesh. We are pleased with the progress of this litigation,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. Firm partner, Jeffrey S. Grand, is serving on the Plaintiffs’ Steering Committee in the federal Ethicon litigation. Bernstein Liebhard LLP continues to evaluate transvaginal mesh lawsuits on behalf of women allegedly injured by pelvic mesh products marketed by Ethicon, Inc. and other manufacturers.

Ethicon Vaginal Mesh Lawsuits
Court documents indicate that more than 4,400 Ethicon transvaginal mesh lawsuits are currently pending in the Southern District of West Virginia. All of the claims allege that the company’s Gynecare pelvic mesh products were defectively designed and manufactured, and caused women to suffer serious vaginal mesh complications, including mesh erosion, scarring, and chronic pain and infection.

Vaginal mesh lawsuits have been mounting since October 2008, when the U.S. Food and Drug Administration (FDA) alerted the public that it had received more than 1,000 reports of serious vaginal mesh complications. In July 2011, the FDA issued a second alert, warning that the frequency of complications associated with transvaginal prolapse repair was “not rare.” While the FDA warnings did not result in any vaginal mesh recall, Ethicon announced in June 2012 that it would stop sales of some of its Gynecare devices, including Prolift mesh, due to commercial concerns.*

The Ethicon litigation is just one of several that have been established in the Southern District of West Virginia for vaginal mesh lawsuits since the FDA issued its alerts. Bernstein Liebhard LLP partner, Jeffrey S. Grand, is also serving on the Plaintiffs Steering Committees for: In re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2326); In Re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2325”); and In re: C.R. Bard, Inc., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2187”).

Johnson & Johnson and its Ethicon unit are also named defendants in more than 4,400 transvaginal mesh lawsuits pending in a multicounty litigation underway in New Jersey’s Atlantic County Superior Court. C.R. Bard faces just over 800 claims filed in a second consolidated proceeding pending before the same judge. Mr. Grand has been named Co-Liaison Counsel in both litigations, and was a member of the trial team for the first Ethicon Prolift trial that concluded in March with an $11 million verdict for the plaintiff. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10; In re: Pelvic Mesh Litigation/Bard, No. L-6339-10)

Alleged victims of serious vaginal mesh complications may be entitled to compensation for their medical bills, pain and suffering, and other injuries. Learn More about the litigation involving transvaginal mesh at Bernstein Liebhard LLP's website. To arrange for a free, no obligation review of your vaginal mesh lawsuit, please contact the Firm today by calling 800-511-5092.

*,, June 4, 2012

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(800) 511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (800) 511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
# # #

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Baron and Budd Has Begun Investigating Claims for Transvaginal Mesh Lawsuits
2. Vaginal Mesh Lawsuit News: Wright & Schulte LLC Applauds Settlement of C.R. Bard Transvaginal Mesh Lawsuit
3. C.R. Bard Settles Its Second Transvaginal Mesh Case in West Virginia Multidistrict Litigation, Notes Parker Waichman LLP
4. Transvaginal Mesh Lawsuit Update: Rottenstein Law Group LLP Comments on Bard Mesh Trial Settlement in W. Va.
5. Transvaginal Mesh Device Caused California Woman Serious Injuries, Alleges Parker Waichman LLP in Lawsuit
6. Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Start of Second Bellwether Trial in Federal C.R. Bard Litigation
7. Transvaginal Mesh Lawsuit News: New CR Bard Mesh Trial Scheduled for Aug. 19, Rottenstein Law Group LLP Reports
8. Vaginal Mesh Lawsuit News: Wright & Schulte LLC Applaud $2 Million Verdict in C.R. Bard Transvaginal Mesh Lawsuit Trial
9. Jury Awards Transvaginal Mesh Patient $2M, Finding that C.R. Bard Failed to Warn of the Dangers of Its Avaulta Pelvic Mesh Device, Notes Parker Waichman LLP
10. Transvaginal Mesh Lawsuit News: Rottenstein Law Group LLP Responds to $2 Million Bard Mesh Trial Verdict
11. Transvaginal Mesh Lawsuit News: Rottenstein Law Group LLP Responds to $250,000 Bard Mesh Trial Verdict
Post Your Comments:
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX ... Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over ... Cut Pro X . Simply select a ProHand generator and drag it above media ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of ... award to iHire in recognition of their exemplary accomplishments in worksite health promotion. , ... Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... KNOXVILLE, Tenn. , June 24, 2016 /PRNewswire/ ... market providing less invasive and more durable cerebrospinal ... million in funding.  The Series-A funding is led ... the Lighthouse Fund, and other private investors.  Arkis, ... less-invasive neurosurgical instrumentation and the market release of ...
(Date:6/23/2016)... Research and Markets has announced the addition ... Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, Binder, ... Forecast to 2021" report to their offering. ... excipients market is projected to reach USD 8.1 Billion ... forecast period 2016 to 2021. The ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: